Summit Therapeutics (SMMT) shares fell 16.5% on Monday, November 16, 2026, after the company said the FDA issued a Complete Response Letter on its application for ivonescimab in a form of lung cancer, the largest percentage move among the four stocks in this brief. Each of the four companies released news on November 15 or 16, and the moves below are from Monday's regular session.
Today's movers
- Summit Therapeutics (SMMT), down 16.5% to $11.82 (prices): the company said the letter indicates its Biologics License Application for ivonescimab cannot be approved in its present form. Read more
- CG Oncology (CGON), up 14.0% to $84.78 (prices): the company said its Phase 3 PIVOT-006 bladder cancer trial met its primary endpoint, with a 68% reduction in the risk of recurrence. Read more
- H World (HTHT), up 8.9% to $54.88 (prices): the hotel group reported third quarter results and raised its 2026 revenue growth guidance to 9% to 10%, from 4% to 8%. Read more
- Tyson Foods (TSN), up 8.7% to $63.95 (prices): the company reported fiscal fourth quarter results and forecast fiscal 2027 adjusted operating income of $1.7 billion to $2.15 billion. Read more
The market
Monday was a regular trading day. The NYSE's holiday calendar lists no closure or early close on November 16, 2026, and its core trading session runs from 9:30 a.m. to 4:00 p.m. ET. This brief does not include index closes.
What we left out
This edition has four mover posts. The five stocks below also moved on Monday, and they are not covered in this edition.
- Accelevation (ACCV) fell 12.9% to $11.25 (prices). Accelevation filed an amended Form 8-K on November 16 correcting two errors in its third quarter earnings release.
- Molina Healthcare (MOH) rose 11.3% to $233.09 (prices).
- Natera (NTRA) fell 9.6% to $288.48 (prices).
- Ciena (CIEN) fell 8.2% to $257.56 (prices). Ciena said in a Form 8-K on November 16 that it appointed Greg Friesen as Executive Vice President and Chief Product Officer.
- Micron Technology (MU) fell 7.6% to $719.02 (prices).
Sources
- SMMT daily prices, November 13 and 16, 2026
- Press release: Summit Therapeutics Provides Update Regarding Ivonescimab Biologics License Application (Exhibit 99.1)
- CGON daily prices, November 13 and 16, 2026
- Press release: PIVOT-006 Phase 3 Registrational Trial results (Exhibit 99.1)
- HTHT daily prices, November 13 and 16, 2026
- Press release: H World Group Limited Reports Third Quarter of 2026 Unaudited Financial Results (Exhibit 99.1 to Form 6-K)
- TSN daily prices, November 13 and 16, 2026
- Press release: Tyson Foods Reports Fourth Quarter and Fiscal 2026 Results (Exhibit 99.1)
- NYSE holidays and trading hours
- ACCV daily prices, November 13 and 16, 2026
- Form 8-K/A, Accelevation Holdings Corp., filed November 16, 2026
- MOH daily prices, November 13 and 16, 2026
- NTRA daily prices, November 13 and 16, 2026
- CIEN daily prices, November 13 and 16, 2026
- Form 8-K, Ciena Corporation, filed November 16, 2026
- MU daily prices, November 13 and 16, 2026


